1. Home
  2. ROMA vs FTH Comparison

ROMA vs FTH Comparison

Compare ROMA & FTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roma Green Finance Limited

ROMA

Roma Green Finance Limited

N/A

Current Price

$5.51

Market Cap

520.6M

Sector

Finance

ML Signal

N/A

Logo Faeth Therapeutics Inc. Common Stock

FTH

Faeth Therapeutics Inc. Common Stock

N/A

Current Price

$7.89

Market Cap

507.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ROMA
FTH
Founded
2018
1999
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
520.6M
507.8M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
ROMA
FTH
Price
$5.51
$7.89
Analyst Decision
Strong Buy
Analyst Count
0
15
Target Price
N/A
★ $56.15
AVG Volume (30 Days)
36.5K
★ 679.1K
Earning Date
12-22-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.16
$8.54
52 Week High
$11.77
$42.14

Technical Indicators

Market Signals
Indicator
ROMA
FTH
Relative Strength Index (RSI) 33.90 23.28
Support Level $4.54 N/A
Resistance Level $8.68 $21.97
Average True Range (ATR) 0.43 1.77
MACD 0.04 -0.45
Stochastic Oscillator 0.00 0.40

Price Performance

Historical Comparison
ROMA
FTH

About ROMA Roma Green Finance Limited

Roma Green Finance Ltd is a professional specialist in the provision of environmental, social and governance (ESG), sustainability and climate change related advisory services through its operating subsidiaries in Hong Kong and Singapore. Its services include Sustainability Program Development, ESG Reporting, Corporate Governance and Risk Management, Climate Change Strategies and Solutions, Environmental Audit, ESG Rating Support and Shareholder Communication, and Education and Training. It operates in one reporting business segment in Hong Kong and Singapore, of which the majority of revenue is derived from Hong Kong.

About FTH Faeth Therapeutics Inc. Common Stock

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Share on Social Networks: